Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17245
Corporate User License Price USD 750
Corporate User License Price INR 51735
Site License Price USD 500
Site License Price INR 34490
Request a Quote

Report Title

Novartis Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Novartis Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Novartis Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Novartis Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG, is a manufacturer of prescription drugs. The company portfolio includes cardio metabolic, ophthalmology, respiratory, neuroscience, immunology and dermatology, oncology, call and gene therapy. It provides medicines such as terbinafine hydrochloride, ceritinib, dabrafenib, nilotinib, rivastigmine tartrate, panobinostat, fingolimod, topotecan, fluvastatin sodium, amlodipine besylate and benazepril hydrochloride, midostaurin, valsartan and hydrochlorothiazide USP and methylphenidate hydrochloride, among others. Novartis markets products in subcutaneous injections, oral granules, soft gelatin capsules, and chewable tablets and suspensions forms. The company offers health education, patient assistance services, healthcare solutions, drug discoveries research and development services. Novartis is headquartered in East Hanover, New Jersey, the US.

Novartis Pharmaceuticals Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Novartis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Novartis Pharma Acquires Immunotherapy Manufacturing Facility From Dendreon For USD 43 Million 11

Partnerships 12

Cure Forward Partners with Novartis Pharma 12

Novartis Pharma Enters into Agreement with Eisai 13

Radius Health Partners with Novartis Pharma for RAD1901 14

Licensing Agreements 15

Intec Pharma Enters into Agreement with Novartis Pharma 15

Equity Offering 16

Altimmune Raises USD14.7 Million in Private Placement of Series B Preferred Shares 16

Asset Transactions 18

Validus Pharma And Wood Creek Capital Management Acquire Six Product Lines From Novartis Pharma 18

Acquisition 20

Novartis Pharma Acquires Selexys Pharma for up to USD665 Million 20

Novartis Pharmaceuticals Corp-Key Competitors 22

Novartis Pharmaceuticals Corp-Key Employees 23

Novartis Pharmaceuticals Corp-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Joint Venture 24

Recent Developments 25

Product News 25

Jul 06, 2018: Novartis and Sandoz withdraw medicines from US over packaging concerns 25

Jul 06, 2018: Sandoz and its affiliate, Novartis Pharmaceuticals voluntarily recall select blister packages of products in the U.S. due to packaging requirements for child resistance 26

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Novartis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts 2

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Novartis Pharmaceuticals Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Novartis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9

Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Novartis Pharma Acquires Immunotherapy Manufacturing Facility From Dendreon For USD 43 Million 11

Cure Forward Partners with Novartis Pharma 12

Novartis Pharma Enters into Agreement with Eisai 13

Radius Health Partners with Novartis Pharma for RAD1901 14

Intec Pharma Enters into Agreement with Novartis Pharma 15

Altimmune Raises USD14.7 Million in Private Placement of Series B Preferred Shares 16

Validus Pharma And Wood Creek Capital Management Acquire Six Product Lines From Novartis Pharma 18

Novartis Pharma Acquires Selexys Pharma for up to USD665 Million 20

Novartis Pharmaceuticals Corp, Key Competitors 22

Novartis Pharmaceuticals Corp, Key Employees 23

Novartis Pharmaceuticals Corp, Joint Venture 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Novartis Pharmaceuticals Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person